A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-/y mice

Authors:

Abstract
Predicting clinical therapeutic outcomes from animal studies using conserved electrophysiological phenotypes could facilitate developing treatments for neuropsychiatric disorders. Alpha oscillations in human resting-state electroencephalogram recordings are altered in many disorders, but whether these disruptions exist in mouse models is unknown. Here, we employed a uniform analytical method to show in males with fragile X syndrome (FXS) that alpha oscillations in humans and alpha-like oscillations in the visual cortex of Fmr1 -/y mice are slowed, with a stronger phenotype in adults than juveniles and a juvenile-specific power phenotype in both species. We find that alpha-like oscillations are disrupted by deletion of Fmr1 in cortical excitatory neurons and glia, reflect differential activity of two classes of GABAergic interneurons, and are more sensitive to activation of GABA B receptors by Arbaclofen in wild-type than Fmr1 -/y mice. Our framework reveals evolutionary conservation of alpha oscillation disruptions, enables a deeper understanding of FXS pathophysiology, and narrows the gap between treatment promise and practice.
Funding Information
  • U.S. Department of Health & Human Services | National Institutes of Health (1K23DC017983-01A1)
  • U.S. Department of Health & Human Services | National Institutes of Health (1T32MH112510)
  • U.S. Department of Health & Human Services | National Institutes of Health (U54HD082008)
  • U.S. Department of Health & Human Services | National Institutes of Health (U54HD104461)
  • U.S. Department of Health & Human Services | National Institutes of Health (K23 HD101416)
  • U.S. Department of Health & Human Services | National Institutes of Health (F31 HD113221-01A1)
  • U.S. Department of Health & Human Services | National Institutes of Health (R01EY023037)
  • U.S. Department of Health & Human Services | National Institutes of Health (R21NS123499)
  • National Science Foundation (GRFP)
  • FRAXA Research Foundation
  • Autism Science Foundation
  • Thrasher Research Fund
  • Harvard Catalyst
  • Simons Foundation (SFARI 575135)
  • RCUK | Biotechnology and Biological Sciences Research Council (BB/S008276/1)